Hao Yang

9PUBLICATIONS
1CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)Predictive and prognostic markersCardiology (incl. cardiovascular diseases)Chemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Mar 11, 2026
Regulatory mechanisms of ALKBH5/CIITA axis in the synergistic modulation of hepatocellular carcinoma radiotherapy and immunotherapy.

Fei Wang, Hui Hou, Hong Yang

|Feb 05, 2026
Caffeine Sodium Benzoate-Induced Macrophage M1 Polarization Promotes Endothelial Progenitor Cell Dysfunction by Inducing Mitochondrial Dysfunction Via Targeting let-7a-5p/OPA1 Axis.

Tianwei Yu, Yuanyuan Yuan, Feiya Suo

|Jan 10, 2026
SYT8 as a potential prognostic biomarker and therapeutic predictor in colorectal cancer: insights from multi-cohort transcriptomic analyses.

Li Feng, Qin Hao, Jing Fan

|Dec 18, 2025
Radiotherapy combined with anti-PD-1 immunotherapy promotes ferroptosis-driven control of hepatocellular carcinoma.

Ting Dou, Xianggao Zhu, Hong Li

|Feb 23, 2025
Caffeine Sodium Benzoate Promotes Endothelial Dysfunction of Human Umbilical Vein Endothelial Cells by Promoting M1 Macrophage Polarization.

Tianwei Yu, Jiale Wei, Lili Tian

|Jul 01, 2024
Cancer-associated fibroblasts-secreted exosomal miR-92a-3p promotes tumor growth and stemness in hepatocellular carcinoma through activation of Wnt/β-catenin signaling pathway by suppressing AXIN1.

Zenong Su, Chao Lu, Feifei Zhang

Pageof 2

Frequent Collaborators

1 joint publications

Xiangcheng Wang